SCHEMBL3136529

SCHEMBL3136529

O=C(O)CCC1c2ccccc2-c2ccccc21

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 3/20 0.54
KMT2A Q03164 1/20 0.49
TSHR P16473 2/20 0.47
CYP1A2 P05177 1/20 0.47
HTR2A P28223 1/20 0.47
APEX1 P27695 1/20 0.43
MAPT P10636 1/20 0.42
KEAP1 Q14145 1/20 0.42
FABP7 O15540 1/20 0.42
FABP5 Q01469 1/20 0.42
HDAC3 O15379 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC7 Q8WUI4 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
HDAC9 Q9UKV0 1/20 0.41
HDAC5 Q9UQL6 1/20 0.41
NCOR2 Q9Y618 1/20 0.41
NR4A2 P43354 1/20 0.41
CA1 P00915 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8993456 0.98 EGFR (0.53) EGFRKMT2ATSHRCYP1A2HTR2A
SCHEMBL27407085 0.91 EDNRB (0.51) EGFRKMT2ATSHRCYP1A2
SCHEMBL8993220 0.90 EGFR (0.58) EGFRKMT2ATSHRCYP1A2HTR2A
SCHEMBL28062991 0.89 KMT2A (0.57) EGFRKMT2ATSHRCYP1A2HTR2A
SCHEMBL9449431 0.86 EGFR (0.45) EGFRKMT2ATSHRCYP1A2
SCHEMBL1567120 0.84 HTR2A (0.47) EGFRKMT2ATSHRCYP1A2HTR2A
SCHEMBL11014266 0.84 EGFR (0.48) EGFRKMT2ATSHRCYP1A2
SCHEMBL23548026 0.82 EGFR (0.55) EGFRKMT2ATSHRCYP1A2HTR2A
SCHEMBL24628375 0.82 POLB (0.47) EGFRKMT2ATSHRCYP1A2HTR2A
SCHEMBL8993450 0.82 HTR2A (0.45) EGFRKMT2ATSHRCYP1A2HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117924669-A Carboxyl functionalized super-crosslinked polymer and preparation method and application thereof 中南民族大学 2024-04-26 CN claimed
CN-118221849-A Application of metallocene catalyst composition as catalyst in preparation of poly alpha olefin wax 亚培烯科技(上海)有限公司 2024-06-21 CN disclosed
CN-110343042-B Synthesis method of 2- ((9-hydrofluoren-9-yl) methyl) malonate 温州大学 2021-10-08 CN disclosed
CN-110256247-B Synthesis method of 2- ((9-hydrofluoren-9-yl) methyl) malonate 温州大学 2021-09-21 CN disclosed
WO-2020230597-A1 POLARIZING PLATE PROTECTIVE FILM AND METHOD FOR PRODUCING SAME, AND POLARIZING PLATE 大阪ガスケミカル株式会社 2020-11-19 WO disclosed
EP-2562156-B1 COLCHICINE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, METHOD FOR PREPARING SAID DERIVATIVES, AND PHARMACEUTICAL COMPOSITION COMPRISING SAID DERIVATIVES ASAN FOUND (KR) 2018-11-07 EP disclosed
US-8927760-B2 Colchicine derivatives or pharmaceutically acceptable salts thereof, method for preparing said derivatives, and pharmaceutical composition comprising said derivatives THE ASAN FOUNDATION (KR) 2015-01-06 US disclosed
US-8927760-B2 Colchicine derivatives or pharmaceutically acceptable salts thereof, method for preparing said derivatives, and pharmaceutical composition comprising said derivatives THE ASAN FOUNDATION (KR) 2015-01-06 US disclosed
US-8927760-B2 Colchicine derivatives or pharmaceutically acceptable salts thereof, method for preparing said derivatives, and pharmaceutical composition comprising said derivatives THE ASAN FOUNDATION (KR) 2015-01-06 US disclosed
EP-2562156-A2 COLCHICINE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, METHOD FOR PREPARING SAID DERIVATIVES, AND PHARMACEUTICAL COMPOSITION COMPRISING SAID DERIVATIVES The Asan Foundation (KR) 2013-02-27 EP disclosed
US-5869605-A Protected compound comprising a protective group removably attached to a compound to be protected RHONE-POULENCCHIMIE (FR) 1999-02-09 US disclosed
US-5519043-A ANTIINFLAMMATORY AGENTS WITH AMIDE, CARBAMATE OR THIOCARBAMATE GROUPS ON FLUORENE AND BENZENE SCIOS NOVA INC. (US) 1996-05-21 US disclosed
US-5472973-A Non-steroidal antiinflammatory agents SCIOS NOVA INC. (US) 1995-12-05 US disclosed
EP-0565607-A1 PROTECTION GROUP, COMPOUD PROTECTED BY THIS GROUP AND DEVICE FOR GRAFTING THE PROTECTION GROUP ONTO THE COMPOUND BEING PROTECTED RHONE-POULENC CHIMIE (FR) 1993-10-20 EP disclosed
WO-1993011764-A1 FLUORENYL DERIVATIVES AND THEIR USE AS ANTI-INFLAMMATORY AGENTS SCIOS NOVA INC. (US) 1993-06-24 WO disclosed
EP-0531443-A4 METHODS FOR TREATING INFLAMMATION AND COMPOUNDS AND COMPOSITIONS SUITABLE FOR USE THEREIN 1993-04-21 EP disclosed
EP-0531443-A1 METHODS FOR TREATING INFLAMMATION AND COMPOUNDS AND COMPOSITIONS SUITABLE FOR USE THEREIN NOVA PHARMACEUTICAL CORPORATION (US) 1993-03-17 EP disclosed
WO-1992012167-A1 PROTECTION GROUP, COMPOUD PROTECTED BY THIS GROUP AND DEVICE FOR GRAFTING THE PROTECTION GROUP ONTO THE COMPOUND BEING PROTECTED RHONE-POULENC CHIMIE (FR) 1992-07-23 WO disclosed
US-5079260-A Side effect reduction; fluorene derivatives NOVA PHARMACEUTICAL CORPORATION (US) 1992-01-07 US disclosed
WO-1991018596-A1 METHODS FOR TREATING INFLAMMATION AND COMPOUNDS AND COMPOSITIONS SUITABLE FOR USE THEREIN WEITZBERG MOSHE (US) 1991-12-12 WO disclosed